Cumberland Pharmaceuticals Inc.

NASDAQ:CPIX

Drug Manufacturers - Specialty & Generic

Healthcare
$6.57 -1.07%

-$0.06 today

Market cap
$98.52M
Beta
0.10
P/E (TTM)
-11.5
EPS (TTM)
-$0.48
52W Low $1.85High $6.61

Volume 0.16M

Average 0.97M

CPIX Depreciation & Amortization

Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.

Cumberland Pharmaceuticals Inc.NASDAQ: CPIX

Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026

Depreciation & amortization declines year over year

Q1 FY2026 depreciation & amortization of $1.28M fell 3.1% year over year, ahead of the -16.3% change in trailing-twelve-month depreciation & amortization. Sequentially, it fell 3.8% from the prior quarter. Over 3 fiscal years it compounded at -0.3% a year.

Context

  • Depreciation & amortization amounted to 11.9% of revenue in FY2025, down 4.1 pp from a year earlier.
  • Depreciation & amortization increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of -3.1% holds above the trailing-twelve-month pace of -16.3%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$1.28M-3.8% QoQ
Last fiscal yearDec 2025
$5.29M-12.5% YoY
LTMMar 2026
$4.96M-16.3% YoY
Depreciation & Amortization past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-3.1%——
1 year-12.5%——
3-year CAGR-0.3%——
5-year CAGR——
10-year CAGR——

Depreciation & Amortization history

USD · from the income statement

Latest · FY2025
5.29M USD
Year-over-year change
-12.5%
4-year CAGR
+3.5%

Depreciation & Amortization vs competitors

How CPIX compares with its peers on the latest reported figures

  • CPIX's LTM Mar 2026 depreciation & amortization of $4.96M is the 2nd highest of the 4 companies compared; the peer median is $18.34K.
  • Its year-over-year change of -16.3% is the 3rd highest of 4, against a peer median of -7.4%.
  • Depreciation & amortization amounts to 11.8% of revenue for CPIX, versus a peer median of 14.1%.
CPIX Competitors Peer median
Depreciation & Amortization for CPIX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CELUCelularity Inc.LTM Dec 2025$7.34M -7.4%-8.2%27.6%
CPIXCumberland Pharmaceuticals Inc.LTM Mar 2026$4.96M -16.3%-0.3%11.8%
DYAIDyadic International, Inc.LTM Mar 2026$18.34K +12.3%—0.6%
LTRNLantern Pharma Inc.LTM Mar 2026$16.56K -74.3%+19.7%—
Peer median (excluding CPIX) $18.34K-7.4%+5.7%14.1%

Competitors are the stored peer set for CPIX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue35.99M42.01M39.55M37.87M44.52M
Cost of Revenue8.81M9.12M6.07M6.59M6.67M
Gross Profit27.17M32.89M33.49M31.28M37.85M
Gross Margin75.5%78.3%84.7%82.6%85.0%
Research & Development5.68M6.69M5.83M4.82M5.57M
Selling, General & Admin24.8M26.84M29.1M28.15M31.05M
Operating Expenses34.85M38.6M43.04M37.71M40.65M
Depreciation & Amortization4.61M5.33M8.1M6.04M5.29M
EBITDA(857.83K)332.92K2.49M182.42K2.96M
EBITDA Margin-2.4%0.8%6.3%0.5%6.6%
Operating Income(7.68M)(5.7M)(9.55M)(6.43M)(2.79M)
Operating Margin-21.3%-13.6%-24.2%-17.0%-6.3%
Interest Income26.08K98.41K286.85K334.44K476.75K
Interest Expense98.03K586K667.86K605.51K495.99K
Other Income / Expenses2.12M123.74K3.27M(33.98K)(32.46K)
Income Before Tax(5.56M)(5.58M)(6.28M)(6.47M)(2.82M)
Pre-Tax Margin-15.5%-13.3%-15.9%-17.1%-6.3%
Income Tax Expense34.89K68.85K45.77K(22.67K)40.26K
Net Income(3.51M)(5.57M)(6.28M)(6.48M)(2.84M)
Net Margin-9.7%-13.3%-15.9%-17.1%-6.4%
EPS (Basic)(0.24)(0.38)(0.44)(0.46)(0.19)
EPS (Diluted)(0.24)(0.38)(0.44)(0.46)(0.19)
Weighted Avg Shares14.9M14.56M14.3M14.06M14.96M
Weighted Avg Shares (Diluted)14.9M14.56M14.3M14.06M14.96M

Cumberland Pharmaceuticals Inc.

NASDAQ:CPIX

Intrinsic Alpha fair value

Locked

Current Price

$6.57

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.